Invesaro

Stocks DIS Financial statements

Financial statements

Walt Disney Co financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Walt Disney Co files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue55,13759,43469,60765,38867,41882,72288,89891,36194,425
Selling, general and administrative8,1768,86011,54912,36913,51716,38815,33615,75916,501
Operating income14,77515,68914,8478,1087,76612,12112,86315,60117,551
Interest expense5076821,2461,647-1,546-1,549-1,973-2,070-1,812
Other non-operating income786014,3571,038201-66796-650
Pre-tax income13,78814,72913,923-1,7432,5615,2854,7697,56912,003
Income tax4,4221,6633,026699251,7321,3791,796-1,428
Net income to minority interests3864685303905123601,0368011,027
Net income8,98012,59811,054-2,8641,9953,1452,3544,97212,404
EBITDA17,55718,70019,01413,45312,87717,28418,23220,59122,877
EPS, basic5.738.406.68-1.581.101.731.292.726.88
EPS, diluted5.698.366.64-1.581.091.721.292.726.85
Shares, basic (weighted)1,5681,4991,6561,8081,8161,8221,8281,8251,804
Shares, diluted (weighted)1,5781,5071,6661,8081,8281,8271,8301,8311,811

Balance sheet

FY2017FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents4,0174,1505,41817,91415,95911,61514,1826,0025,695
Receivables9,33415,48112,70813,36712,65212,33012,72913,217
Inventory1,3921,6491,5831,3311,7421,9632,0222,134
Other current assets6359798758171,1991,2862,3911,158
Total current assets16,82528,12435,25133,65729,09832,76325,24124,267
Property, plant and equipment29,54031,60332,07832,62433,59634,94137,04141,255
Lease right-of-use assets3,8953,9664,2113,3763,170
Goodwill31,42631,26980,29377,68978,07177,89777,06773,32673,294
Intangible assets6,81223,21519,17317,11514,83713,06110,7399,272
Long-term investments2,8993,2243,9033,9353,2183,0804,4598,097
Other non-current assets3,3654,7158,4338,6589,20811,07613,10110,002
Total assets98,598193,984201,549203,609203,631205,579196,219197,514
Accounts payable6,50313,77813,18316,35716,20515,12514,79615,055
Accrued liabilities2,1893,0102,9253,4823,4473,0613,6723,587
Deferred revenue4,5914,0503,6884,0675,5315,5685,5875,689
Short-term debt3,7908,8575,7115,8663,0704,3306,8456,711
Total current liabilities17,86031,34126,62831,07729,07331,13934,59934,162
Long-term debt17,08438,12952,91748,54045,29942,10138,97035,315
Lease liabilities2,9833,0203,2582,7682,710
Other non-current liabilities6,59013,76017,20414,52212,51812,06910,8519,901
Total liabilities45,766100,095113,286110,598104,752101,62290,69782,902
Total debt20,87446,98658,62854,40648,36946,43145,81542,026
Paid-in capital36,77953,90754,49755,47156,39857,38358,59259,814
Retained earnings82,67942,49438,31540,42943,63646,09349,72260,410
Treasury stock-67,588-907-907-907-907-907-3,919-7,441
Other comprehensive income-3,528-3,097-6,617-8,322-6,440-4,119-3,292-3,699-2,914
Shareholders' equity48,77388,87783,58388,55395,00899,277100,696109,869
Minority interests4,0595,0124,6804,4583,8714,6804,8264,743
Total equity52,83293,88988,26393,01198,879103,957105,522114,612
Total liabilities and equity98,598193,984201,549203,609203,631205,579196,219197,514
Shares outstanding1,8001,8001,9001,900

Cash flow statement

FY2017FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income9,36613,06611,584-2,4742,5073,5053,3905,77313,431
Depreciation and amortization2,7823,0114,1675,3455,1115,1635,3694,9905,326
Stock-based compensation3643937115256009771,1431,3661,363
Deferred income tax344-1,5812,076-275-1,252168-1,365-807-2,617
Change in receivables107-720551,943-357605358-565-283
Change in inventory-5-17-22314252-420-183-42-114
Change in payables-368235191-2,2932,410964-1,142156237
Cash from operations12,34314,2955,9847,6165,5666,0029,86613,97118,101
Capital expenditures-3,623-4,465-4,876-4,022-3,578-4,943-4,969-5,412-8,024
Cash from investing-4,111-5,336-15,096-3,850-3,171-5,008-4,641-6,881-8,043
Debt issued4,8201,05638,24018,12064333831321,057
Debt repaid-2,364-1,871-38,881-3,533-3,737-4,016-1,675-3,064-3,735
Stock issued2762103183054351275288233
Share buybacks-9,368-3,5770000-2,992-3,500
Dividends paid-2,445-2,515-2,895-1,587000-1,366-1,803
Cash from financing-8,959-8,843-4648,480-4,385-4,729-2,724-15,288-10,366
Exchange rate effect31-25-983830
Net change in cash-696911,30012,499-1,951-4,3422,574-8,133-303
Free cash flow8,7209,8301,1083,5941,9881,0594,8978,55910,077
Interest paid4666311,1421,5591,8921,6852,1102,1342,050
Income taxes paid3,8012,5039,2597381,6381,0971,1933,9631,221

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $106.15 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin18.4%Operating income / revenue.
EBITDA margin24.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin12.9%Pre-tax income / revenue.
Net margin8.7%Net income / revenue.
FCF margin8.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin17.2%Cash from operations / revenue.
Effective tax rate27.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)7.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)4.2%Net income / average total assets.
Return on invested capital (ROIC)8.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue16.8%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue8.8%Capital expenditures / revenue.
D&A / revenue5.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y3.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y7.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y12.5%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y13.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y16.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y11.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y9.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y11.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y149.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y58.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y151.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y58.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y29.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y44.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y18.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y17.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y111.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y22.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y9.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y5.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y5.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y0.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-1.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-0.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.71xCurrent assets / current liabilities.
Quick ratio0.56x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.15x(Cash + short-term investments) / current liabilities.
Debt / equity0.42xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets22.5%Total debt / total assets.
Liabilities / assets42.9%Total liabilities / total assets.
Net debt$40.86BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.72xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital-$10.21BCurrent assets - current liabilities.
Goodwill and intangibles / assets41.3%(Goodwill + intangible assets) / total assets.
Tangible book value$25.56BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.48xRevenue / average total assets.
Fixed asset turnover2.21xRevenue / average property, plant and equipment.
Receivables turnover6.79xRevenue / average receivables.
Days sales outstanding54 days365 x average receivables / revenue.
FCF conversion96.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow51.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$4.93Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$56.72Revenue / diluted weighted shares.
FCF per share$4.76Free cash flow / diluted weighted shares.
Operating cash flow per share$9.75Cash from operations / diluted weighted shares.
Book value per share$63.13Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$14.67Tangible book value / shares outstanding.
Cash per share$2.97(Cash + short-term investments) / shares outstanding.
Buybacks / FCF99.5%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$183.29BShare price x shares outstanding.
Enterprise value$224.14BMarket cap + total debt - cash - short-term investments.
P/E21.3xMarket cap / net income. Only when net income is positive.
P/S1.85xMarket cap / revenue.
P/B1.67xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book7.17xMarket cap / tangible book value, when positive.
P/FCF22.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF10.8xMarket cap / cash from operations, when positive.
EV/Sales2.27xEnterprise value / revenue.
EV/EBIT12.3xEnterprise value / operating income, when both are positive.
EV/EBITDA9.43xEnterprise value / EBITDA, when both are positive.
EV/FCF27.0xEnterprise value / free cash flow, when both are positive.
FCF yield4.5%Free cash flow / market cap.
Earnings yield4.7%Net income / market cap (the inverse of P/E).
Shareholder yield4.5%(Dividends paid + share buybacks) / market cap.
PEG0.36xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Walt Disney Co's revenue in fiscal 2025?

Walt Disney Co reported revenue of $94.43B for fiscal 2025, 3.4% higher than the year before.

Was Walt Disney Co profitable in fiscal 2025?

Yes. Net income was $12.40B, a net margin of 13.1%.

How much free cash flow did Walt Disney Co generate in fiscal 2025?

Cash from operations of $18.10B minus capital expenditures of $8.02B left free cash flow of $10.08B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Walt Disney Co